Compare KFY & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KFY | ICUI |
|---|---|---|
| Founded | 1969 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.6B |
| IPO Year | 1998 | 1995 |
| Metric | KFY | ICUI |
|---|---|---|
| Price | $81.19 | $160.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $73.00 | ★ $169.00 |
| AVG Volume (30 Days) | ★ 504.8K | 242.0K |
| Earning Date | 06-17-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.90% | N/A |
| EPS Growth | 13.48 | ★ 100.62 |
| EPS | ★ 5.22 | 1.20 |
| Revenue | $1,819,519,000.00 | ★ $2,231,262,000.00 |
| Revenue This Year | $6.92 | N/A |
| Revenue Next Year | $3.25 | $4.46 |
| P/E Ratio | ★ $14.99 | $131.20 |
| Revenue Growth | ★ 12.20 | N/A |
| 52 Week Low | $58.27 | $107.02 |
| 52 Week High | $79.97 | $162.85 |
| Indicator | KFY | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 68.15 | 60.35 |
| Support Level | $66.27 | $139.88 |
| Resistance Level | N/A | $161.30 |
| Average True Range (ATR) | 1.77 | 4.67 |
| MACD | 0.43 | -0.55 |
| Stochastic Oscillator | 99.91 | 79.16 |
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.